Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | BACE1 | P56817 | 9/20 | 0.45 |
| ▸ | REN | P00797 | 1/20 | 0.44 |
| ▸ | CTSS | P25774 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7270371 | 0.90 | CTSD (0.44) | BACE1 | |
| Hydrochloric Acid SCHEMBL8536811 | 0.84 | CTSD (0.40) | BACE1 | |
| SCHEMBL7268854 | 0.81 | KLK5 (0.45) | KLK5ATMREN | |
| SCHEMBL9848360 | 0.80 | KLK5 (0.63) | KLK5ATMCTSS | |
| SCHEMBL7270592 | 0.80 | KLK5 (0.63) | KLK5ATMCTSS | |
| SCHEMBL8539911 | 0.78 | PSEN1 (0.56) | KLK5ATMRENCTSS | |
| SCHEMBL7269627 | 0.78 | PSEN1 (0.56) | KLK5ATMRENCTSS | |
| SCHEMBL6445320 | 0.78 | KLK5 (0.63) | KLK5ATMCTSS | |
| SCHEMBL8532202 | 0.78 | KLK5 (0.63) | KLK5ATMCTSS | |
| SCHEMBL6446193 | 0.78 | KLK5 (0.63) | KLK5ATMCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0839798-A2 | Intermediates for preparating non-peptide retroviral protease inhibitors | ABBOTT LABORATORIES (US) | 1998-05-06 | — | — | EP | disclosed |
| US-5670675-A | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1997-09-23 | — | — | US | disclosed |
| US-5545750-A | TREATING HUMAN IMMUNODEFICIENCY VIRUS | ABBOTT LABORATORIES (US) | 1996-08-13 | — | — | US | disclosed |
| US-5142056-A | Human immunodeficiency virus protease inhibitor | ABBOTT LABORATORIES (US) | 1992-08-25 | — | — | US | disclosed |
| EP-0402646-A1 | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1990-12-19 | — | — | EP | disclosed |